Low-dose testosterone in non-binary athletes: what the evidence says
Quick answer
Low-dose testosterone in non-binary individuals is a recognized gender-affirming care approach, typically targeting partial virilization rather than full male-range androgen levels. Body composition changes including lean mass gain and fat redistribution are documented in studies such as Cocchetti et al. (2021), though effects vary by baseline hormones, dose, and individual response. Athletic performance implications, particularly for hybrid athletes combining strength and endurance training, are understudied and should not be extrapolated from single anecdotal cases.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What's this video probably claiming?
Based on the caption and hashtags, this creator is documenting a year of low-dose testosterone use as a non-binary person who trains for both strength and endurance. The likely claims include: 10kg of body mass gained (split between muscle and fat), improved strength and cardiovascular performance, and visible physical changes concentrated in the upper body. The framing as a "hybrid athlete" suggests this person is balancing resistance training with aerobic work, which is genuinely relevant because testosterone affects those two systems differently. The video probably positions low-dose testosterone as compatible with, or even enhancing for, endurance sports, not just lifting. That's a more nuanced claim than the typical "TRT made me strong" content, and it deserves a more nuanced look. The creator appears to be sharing lived experience rather than prescribing a protocol, which is the right framing. Whether the claims hold up to what controlled studies actually show is another question.
What does the science actually show?
Testosterone's effects on muscle mass and strength are real and dose-dependent. A landmark study by Bhasin et al. (1996, NEJM) showed that even supraphysiologic doses produced lean mass gains of roughly 6kg over 10 weeks in healthy men without training. At lower, replacement-range doses, the effects are more modest. A 2022 review by Roberts et al. in the Journal of Clinical Endocrinology and Metabolism found that transgender men on testosterone therapy gained significant lean mass within 12 months, but fat distribution changes were slower and less complete. The 10kg total mass gain described here over 12 months is plausible, though the muscle-to-fat ratio depends heavily on training, diet, and baseline hormone levels. On the endurance side, testosterone increases red blood cell production and VO2max, but data from Hilton and Roberts (2021, British Journal of Sports Medicine) show these adaptations are not fully reversed even after months of testosterone suppression, complicating the picture for athletic contexts.
Where does the social media noise diverge from clinical reality?
The biggest gap between creator content and clinical evidence here is around the idea that "low-dose" testosterone is a clean, predictable category. It isn't. Doses described as low vary wildly across content creators, ranging from 25mg weekly to well above replacement thresholds, and the physiological effects depend heavily on baseline endogenous levels, injection frequency, ester used, and individual aromatization rates. What counts as low-dose for someone with naturally higher baseline testosterone is not the same as for someone with clinically confirmed hypogonadism. A second divergence involves the hybrid athlete framing. Some content implies testosterone uniformly boosts both strength and cardio simultaneously. But testosterone-driven erythropoiesis, which raises red blood cell count, is also what gives testosterone use in endurance sports its most significant performance edge. That distinction rarely gets discussed honestly in these videos. The creator's experience is real. Generalizing it as a template for others is where problems start.
What should you actually know?
If you are considering testosterone therapy for gender affirmation or hormone optimization, the clinical pathway matters. Legitimate low-dose protocols for non-binary individuals are an active area of endocrinology research, with studies like Cocchetti et al. (2021, Journal of Clinical Medicine) examining "gender-affirming hormone therapy with low doses" and documenting partial virilization as the intended outcome. This is a medically recognized approach, not a fringe one. However, the effects on athletic performance, body composition, and long-term cardiovascular health are not as well-characterized in this population as TRT for hypogonadism in cisgender men. Monitoring hematocrit, lipid panels, liver enzymes, and endogenous hormone suppression is standard of care, not optional. Anyone watching this video and thinking about replicating a protocol based on a TikTok creator's self-reported dose and experience is skipping several steps that exist for real safety reasons. A video can document experience. It cannot replace a clinical evaluation.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Low-dose testosterone in non-binary athletes: what the evidence says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Emerging pharmacotherapies for obesity: A systematic review
Broad context for new and established obesity-drug categories.
PubMed
Glucagon-like receptor agonists and next-generation incretin-based medications
Current review for incretin-based obesity medications and cardiometabolic effects.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
Low-dose testosterone in non-binary athletes: what the evidence says should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
Use the health tools and supporting evidence to prepare questions for your clinician.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Low-dose testosterone in non-binary individuals is a recognized gender-affirming care approach, typically targeting partial virilization rather than full male-range androgen levels.
FormBlends verdict
Low-dose testosterone in non-binary individuals is a recognized gender-affirming care approach, typically targeting partial virilization rather than full male-range androgen levels. Body composition changes including lean mass gain and fat redistribution are documented in studies such as Cocchetti et al. (2021), though effects vary by baseline hormones, dose, and individual response. Athletic performance implications, particularly for hybrid athletes combining strength and endurance training, are understudied and should not be extrapolated from single anecdotal cases.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Low-dose testosterone in non-binary individuals is a recognized gender-affirming care approach, typically targeting partial virilization rather than full male-range androgen levels. Body composition changes including lean mass gain and fat redistribution are documented in studies such as Cocchetti et al. (2021), though effects vary by baseline hormones, dose, and individual response. Athletic performance implications, particularly for hybrid athletes combining strength and endurance training, are understudied and should not be extrapolated from single anecdotal cases.
- Low-dose testosterone for non-binary gender affirmation is a clinically recognized approach, but 'low-dose' has no universal definition and effects vary significantly by individual.
- A 10kg mass gain over 12 months on testosterone is biologically plausible, though the muscle-to-fat ratio depends heavily on training, diet, and baseline hormone status, not testosterone alone.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Low-dose testosterone for non-binary gender affirmation is a clinically recognized approach, but 'low-dose' has no universal definition and effects vary significantly by individual.
- A 10kg mass gain over 12 months on testosterone is biologically plausible, though the muscle-to-fat ratio depends heavily on training, diet, and baseline hormone status, not testosterone alone.
- Testosterone improves both strength and endurance performance partly through erythropoiesis, raising red blood cell count. These two effects are not as separable as hybrid athlete content often implies.
- Hilton and Roberts (2021, BJSM) found that testosterone-driven performance advantages in endurance contexts persist beyond hormone level normalization, a finding with real implications for athletic competition.
- Standard monitoring for anyone on testosterone includes hematocrit, lipid panels, liver enzymes, and endogenous hormone levels. This is non-negotiable care, not optional optimization.
- Anecdotal n=1 self-experiments shared on social media can be genuine and informative, but they cannot substitute for individualized clinical evaluation before starting or adjusting hormone therapy.
- Cocchetti et al. (2021) is one of the few studies examining partial-virilization protocols specifically. The research base for non-binary hormone regimens is still thin compared to binary transition literature.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Lucinda | Trans+ Online Coach · TikTok creator
6.7K views on this video
One year on low-dose testosterone as a non-binary hybrid athlete: Here’s what happened to my body! ⤵️ In the last year, I’ve gained about 10kg—some muscle, some fat—and gotten noticeably thicker, especially in my back, arms, and shoulders. My strength and cardio are at an all-time high, but I’ve put in the work for that, with T helping enhance my performance. 🏃🏻🏋🏻 My T levels are now sitting at 19.6, which is perfect for my slow transition. 💫 I'm feeling great overall, though periods have
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Not medical advice. This video was made by Lucinda | Trans+ Online Coach, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.